AR and posterior cortical atrophy: Since PCa AR-V7 expression is associated with tumors that are refractory to AR-targeting therapies, AR-V7 expression in salivary duct carcinomas may serve a similar function; hence, detection of AR-SV in salivary duct malignancies may allow for better stratification of patients that would benefit from AR-targeting treatments.